Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Sep 7.
Published in final edited form as: Placenta. 2023 Jul 28;140:60–65. doi: 10.1016/j.placenta.2023.07.296

Macroscopic lesions of maternal and fetal vascular malperfusion in stillborn placentas: diagnosis in the absence of microscopic histopathological examination

Tess EK Cersonsky 1, Robert M Silver 2, George R Saade 3, Donald J Dudley 4, Uma M Reddy 5, Halit Pinar 1,6
PMCID: PMC10530266  NIHMSID: NIHMS1923000  PMID: 37536149

Abstract

Introduction

Lesions of maternal vascular malperfusion (MVM) and fetal vascular malperfusion (FVM) are common in placentas associated with both stillbirth and live birth. The objective of this study was to identify lesions present more commonly in stillborn placentas and those most indicative of MVM and FVM without microscopic pathologic evaluation.

Methods

Data were derived from the Stillbirth Collaborative Research Network. Lesions were identified according to standard protocols published previously and categorized as either MVM or FVM according to the Amsterdam Placental Workshop Group Consensus Statement and macroscopic “umbilical cord at risk” findings. Multivariate logistic regression was used to determine the odds of stillbirth with macroscopic findings of MVM or FVM.

Results

595 stillbirths and 1,305 live births were analyzed. FVM lesions (85.2%) were marginally more common (though not statistically different) in stillbirths compared to MVM lesions (81.3%). Macroscopic findings of both MVM and FVM were more common in stillbirths versus livebirths (p <0.001). Odds ratios of macroscopic MVM and FVM lesions for stillbirth, adjusted for gestational age at delivery, maternal race (minority), ethnicity (Hispanic), age, and history of hypertension or diabetes, were 1.48 (95% CI 1.30 - 1.69) and 1.34 (95% CI 1.18 - 1.53), respectively.

Discussion

Macroscopic features of MVM and FVM are associated with higher odds of stillbirth versus live birth even when controlled for gestational age and maternal factors, which may be a useful clue in determining the pathophysiology of these events. This information is also useful for pathologists when microscopic examination is not available.

Keywords: Maternal vascular malperfusion, fetal vascular malperfusion, stillbirth, macroscopic evaluation

Introduction

The relationship between maternal and fetal placental lesions and adverse perinatal outcomes has been thoroughly studied. However, results are mixed regarding the association between such lesions and perinatal mortality [1-4]. While placental pathologies represent the largest category of cause of intrauterine death, maternal vascular malperfusion (MVM) and fetal vascular malperfusion (FVM) are variably linked to perinatal mortality, with lesions present at similar rates in fetal and neonatal deaths [3,5-7].

A recent prospective observational study by Kulkarni et al. (2021) sought to characterize these lesions in stillbirths, neonatal deaths, and livebirths [1]. These authors reported lesions associated with FVM at a rate of only 19.0% compared to MVM at 58.4% in placentas associated with fetal deaths. However, the rate of FVM among placentas associated with fetal death (19.0%) was higher than that of placentas associated with livebirth (8.3%). This study further found that MVM, but not FVM, was associated with maternal hypertension, small for gestational age fetuses, and antepartum hemorrhage.

This study did not assess the relative presence of macroscopic and microscopic lesions of MVM or FVM among placentas, an issue of import for hospitals without dedicated perinatal pathologists given the limited number of trained placental pathologists in the field [8]. The presence or absence of such lesions may have implications in assessing factors that contributed to an adverse outcome [9,10]. Therefore, it is important to be able to identify MVM or FVM lesions regardless of specialized perinatal pathology training and particularly without the use of placental microscopy.

Therefore, we sought to first compare the presence of FVM or MVM lesions among stillbirths and livebirths by presenting both macroscopic and microscopic findings associated with these pathologic phenomena. We then sought to understand how macroscopic placental features of vascular malperfusion may be able to classify placentas as related to stillbirth or livebirth. This builds upon previous work by both identifying which findings are present within stillbirths versus livebirths, and also which may be observed in the absence of microscopic pathologic evaluation.

Materials and Methods

Data were collected as part of the Stillbirth Collaborative Research Network (SCRN), a study of stillbirths and livebirths completed at 59 hospitals in five geographic regions from 2006 to 2009. All study procedures were approved by each center’s Institutional Review Board and by the Data Coordinating and Analysis Center. Patients gave written informed consent to participate. Inclusion and exclusion criteria for SCRN, as well as data collection procedures, have been described previously; all singleton stillbirths or livebirths of gestational age greater than 20 weeks who had undergone placental examination were included [11]. Participants completed an interview at which demographics, maternal health history, and current pregnancy history were collected. For stillbirths, cause of death was determined utilizing the INCODE system, as described previously [12]. For additional analyses, livebirths were stratified as preterm (<37 weeks) or term (≥37 weeks).

Placentas included in these analyses were associated with a livebirth or stillbirth of a singleton fetus (i.e. multiples were excluded) and were examined utilizing the SCRN placental examination protocol, as described previously [13]. Stillborn fetuses were examined according to the SCRN postmortem examination protocol [14]. All infants were weighed and examined for nuchal cord or cord entanglement. Placental weight was classified as small for gestational age (SGA) if below 10th percentile for gestational age, according to established standards [15]. Lesions were classified as MVM or FVM according to previously published standards, including the Amsterdam Placental Workshop Group Consensus Statement [16-18]. Lesions were identified as macroscopic (i.e., observable on gross examination) or microscopic. We also included macroscopic “umbilical cord at risk” findings (according to Redline et al., 2018) not explicitly listed in the Amsterdam criteria for FVM, including marginal, velamentous, and furcate insertion, single umbilical artery, increased cord coiling, umbilical cord knots, and nuchal cord entanglement [17].

Analyses were conducted using R Studio software (R version 4.1.3). Demographic, placental, and lesion characteristics were compared between livebirths and stillbirths utilizing Mann-Whitney tests (continuous variables) and Chi-square or Fisher Exact tests (categorical variables). P-values for significance were set utilizing a Bonferroni correction for multiple comparisons for each analysis.

Multivariate logistic regression was conducted with the purpose of determining if macroscopic MVM or FVM placental findings were associated with stillbirths or livebirths. Macroscopic MVM or FVM findings were entered into regression alone, then entered controlling for several maternal factors (history of hypertension or diabetes, minority race, Hispanic ethnicity, and maternal age). Accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were collected for the model; unadjusted odds ratio (OR) or adjusted odds ratio (aOR) with 95% confidence intervals (95% CI) were collected for each covariate.

Results

Sample characteristics

Five-hundred and ninety-five (595) stillbirths and 1,305 livebirths (includes preterm and term, unless otherwise indicated) were analyzed (Table 1, Supplemental Figure 1). There were no significant differences in maternal age, ethnicity, or race between the two groups; stillbirth was associated with fewer years of education, previous stillbirth, and higher body mass index. Stillbirths were associated with significantly younger gestational age at birth than livebirths (28.66 ± 6.59 weeks versus 36.38 ± 5.46 weeks, p<0.001) and significantly lower fetal and placental disc weight. Among livebirths, preterm livebirths were less likely to have undergone induction of labor (15.5% versus 31.9%, p <0.001). Overall dimensions of the placental disc and umbilical cord were smaller in specimens associated with stillbirth versus livebirths (p<0.001); there was an increased rate of nuchal cord in livebirths versus stillbirths but more nuchal loops in stillbirths versus livebirths (not significant when adjusted for multiple comparisons).

Table 1:

Sample characteristics

Livebirth
(n = 1305)
Stillbirth
(n = 582)
p-
Value1
Demographics Maternal age (years) 27.8 +/− 6.1 27.7 +/− 6.7 0.5
Paternal age (years) 29.8 +/− 7.2 29.4 +/− 7.4 0.3
Ethnicity (Hispanic) 470 (36.0) 215 (36.9) 0.7
Race (minority) 934 (71.6) 216 (37.1) <0.001
 Black 795 (61.3) 147 (25.4) <0.001
 American Indian 5 (0.4) 2 (0.3) 0.9
 Asian 46 (3.5) 35 (6.1) 0.013
 Pacific Islander 12 (0.9) 4 (0.7) 0.8
 Other 106 (8.2) 59 (10.2) 0.2
Education (years) 132 +/− 3.1 12.8 +/− 3.0 0.003
Previous pregnancy 1305 (100.0) 561 (96.4) <0.001
Previous stillbirth 0 (0.0) 42 (7.2) <0.001
Maternal health history Body mass index 26.4 +/− 7.0 27.5 +/− 7.2 0.001
Any chronic condition 449 (34.4) 196 (33.7) 0.8
Hypertension 192 (15.5) 81 (14.9) 0.7
Diabetes 41 (3.3) 32 (5.9) 0.012
Sexually transmitted infection 170 (13.0) 89 (15.3) 0.2
Current pregnancy Gestational age at birth 36.4 +/− 5.5 28.7 +/− 6.6 <0.001
Alcohol use 502 (40.6) 217 (40.0) 0.8
Tobacco use 181 (14.6) 107 (19.7) 0.007
Clinical abruption 51 (7.6) 70 (18.4) <0.001
Fetal sex (female) 647 (49.7) 233 (46.8) 0.3
Birth weight (g) 2909.6 +/− 1046.1 1364.8 +/− 1157.6 <0.001
Delivery Vaginal 839 (64.3) 492 (84.5) <0.001
Induction of labor 355 (28.3) 352 (63.0) <0.001
PTB 43 (15.5) <0.001 2
TB 312 (31.9)
Preterm labor 184 (27.0) 102 (25.8) 0.7
PTB 180 (68.4) <0.001 2
TB 4 (1.0)
Pre-labor rupture of membranes 117 (17.1) 80 (20.1) 0.2
PTB 104 (39.7) <0.001 2
TB 13 (3.1)
Placental disc examination Disc weight (g) 403.7 +/− 135.3 240.4 +/− 152.0 <0.001
Intact placental disc 1171 (92.2) 509 (88.7) 0.014
Round disc 584 (45.7) 246 (43.9) 0.5
Dimensions (cm)
 Longest diameter 19.1 +/− 3.5 15.1 +/− 3.9 <0.001
 Shortest diameter 15.8 +/− 2.9 12.1 +/− 3.3 <0.001
 Thickest portion 2.3 +/− 0.7 2.1 +/− 0.8 <0.001
 Thinnest portion 1.3 +/− 06 1.2 +/− 0.5 <0.001
Irregular lobular pattern 71 (5.6) 46 (8.4) 0.025
Umbilical cord & membrane examination Segments received 12 +/− 07 1.2 +/− 0.6 0.069
Dimensions (cm)
 Length 36.0 +/− 16.7 33.3 +/− 17.1 <0.001
 Thinnest diameter 1.0 +/− 0.4 0.9 +/− 0.4 <0.001
 Thickest diameter 1.5 +/− 0.4 1.4 +/− 0.6 <0.001
Mass present 4 (0.3) 5 (0.9) 0.14
Decreased coiling (≤ 3 in 10cm) 910 (73.8) 358 (66.8) 0.003
Increased coiling (>3 in 10 cm) 323 (26.2) 178 (33.2) 0.003
Nuchal cord 287 (90.8) 83 (66.4) <0.001
 Number of loops 1.2 +/− 0.5 1.4 +/− 0.7 0.004
% Circumvallate membrane 1.1 +/− 9.1 1.8 +/− 11.3 0.12
% Circummarginate membrane 5.7 +/− 17.6 11.4 +/− 25.8 <0.001

All values are represented as mean ± standard deviation or number (percent).

1

Mann-Whitney test, Chi-Square test, or Fisher Exact test.

2

Chi-Square or Fisher Exact test comparing preterm births (PTB) versus term births (TB) among livebirths.

P-values considered significant for <0.0013 with Bonferroni correction for multiple comparisons.

Overall, FVM lesions (85.2%) were marginally more common in stillbirths compared to MVM lesions (81.3%), though this finding was not statistically significant (Tables 2-3). 402 (69.1%) stillborn and 543 (41.6%) liveborn placentas displayed features of both MVM and FVM, whereas 231 (39.7%) stillborn and 279 (21.4%) liveborn placentas displayed macroscopic features of both phenomena. Prevalence of such lesions were also significantly higher in stillbirths versus preterm livebirths (Figure 1). Furthermore, macroscopic and microscopic findings of MVM and FVM were more common among stillbirths compared to term and preterm livebirths; in post-hoc comparisons, all were significantly more common in stillbirths versus preterm livebirths except for microscopic MVM lesions.

Table 2:

Lesions associated with Fetal Vascular Malperfusion (FVM)

Livebirth Stillbirth p-Value1
Any FVM lesion 774 (59.3) 496 (85.2) <0.001
Macroscopic features – umbilical cord 630 (48.3) 357 (61.3) <0.001
 Marginal insertion 158 (12.1) 117 (20.1) <0.001
 Velamentous insertion 19 (1.5) 25 (4.5) <0.001
  Length of unprotected cord (cm) 0.13 +/− 1.09 0.47 +/− 2.13 <0.001
 Furcate insertion 36 (2.9) 9 (1.6) 0.12
  Length of unprotected cord (cm) 0.08 +/− 0.46 0.15 +/− 1.28 0.8
 Knot
  True knot 13 (1.0) 6 (1.0) 0.9
  False knot 184 (17.3) 68 (23.3) 0.020
 Single umbilical artery 28 (2.2) 41 (7.2) <0.001
 Increased coiling (>3 coils/10 cm) 323 (26.2) 178 (33.2) 0.003
 Nuchal cord entanglement 38 (20.0) 35 (50.7) <0.001
Microscopic features 291 (22.3) 360 (61.9) <0.001
 Distal villous immaturity 84 (6.5) 99 (17.1) <0.001
  Diffuse distribution 43 (51.2) 55 (55.6) <0.001
  Focal distribution 41 (48.8) 44 (44.4)
 Avascular villi 91 (7.1) 118 (20.3) <0.001
  Diffuse distribution 1 (1.1) 24 (20.3) <0.001
  Focal distribution 90 (98.9) 94 (79.7)
 Stromal-vascular karyorrhexis 21 (1.6) 180 (31.0) <0.001
  Diffuse distribution 1 (4.8) 29 (16.1) 0.14
  Focal distribution 20 (95.2) 151 (83.9)
 Fetal vascular thrombi present 131 (10.0) 155 (26.6) <0.001
  Thrombi with complete occlusion 15 (1.1) 38 (6.5) <0.001
  Thrombi with degenerative changes 23 (1.8) 7 (1.3) 0.4

All values are represented as mean ± standard deviation or number (percent).

1

Mann-Whitney test, Chi-Square test, or Fisher Exact test. P-values considered significant for < 0.002 with Bonferroni correction for multiple comparisons.

Table 3:

Lesions of the placental disc associated with Maternal Vascular Malperfusion (MVM)

Livebirth Stillbirth p-Value1
Any MVM lesion 856 (65.6) 473 (81.3) <0.001
Macroscopic features 570 (43.7) 370 (63.6) <0.001
 Placenta small for gestational age 511 (39.8) 313 (54.8) <0.001
 Retroplacental hematoma 78 (6.1) 126 (22.7) <0.001
Microscopic features 560 (42.9) 324 (55.7) <0.001
 Accelerated villous maturity 82 (6.3) 101 (18.3) <0.001
 Distal villous hypoplasia 117 (9.1) 68 (11.8) 0.071
  Diffuse distribution 26 (22.2) 15 (22.1) 0.9
  Focal distribution 91 (77.8) 53 (77.9)
 Increased syncytial knots 325 (25.2) 126 (21.8) 0.11
  Diffuse distribution 0 (0.0) 0 (0.0) 1.00
  Focal distribution 325 (100.0) 126 (100.0)
 Decidual arteriopathy 48 (3.7) 74 (12.8) <0.001
 Parenchymal infarction 213 (16.5) 164 (28.4) <0.001
  Diffuse distribution 1 (0.5) 16 (9.8) <0.001
  Focal distribution 212 (99.5) 148 (90.2)

All values are represented as mean ± standard deviation or number (percent).

1

Mann-Whitney test, Chi-Square test, or Fisher Exact test. P-values considered significant for <0.004 with Bonferroni correction for multiple comparisons.

Figure 1: Maternal and fetal vascular malperfusion, microscopic and macroscopic lesions, according to stillbirth versus preterm livebirth versus term livebirth status.

Figure 1:

Percent of each lesion among term livebirths, preterm livebirths, and stillbirths. P-values are shown for among group analyses and between group comparisons of preterm livebirths versus stillbirths (both Chi-Square); bolded p-values indicate statistical significance (p < 0.05).

Fetal vascular malperfusion

Significantly more stillbirths had any FVM lesion compared to livebirths (85.2% versus 65.6%, p <0.001; Table 2). Both macroscopic and microscopic findings of FVM were more likely to be identified in stillbirths versus livebirths (p <0.001).

Among macroscopic lesions, placentas associated with stillbirth were more likely to have marginal or velamentous umbilical cord insertion, single umbilical artery, and nuchal cord entanglement than those associated with livebirth. Increased cord coiling was observed at a higher frequency in stillbirths versus livebirths but was not statistically significant when controlled for multiple comparisons.

Among microscopic lesions, placentas associated with stillbirth were more likely to show distal villous immaturity, avascular villi, stromal-vascular karyorrhexis, and thrombi of the fetal vessels compared to those associated with livebirths. Diffuse lesions were more common than focal lesions in stillbirths versus livebirths in the categories of distal villous immaturity and avascular villi. Fetal vascular thrombi with complete occlusion were also more common among placentas associated with stillbirths versus livebirths.

Maternal vascular malperfusion

Significantly more stillbirths had any MVM lesion compared to livebirths (81.3% versus 65.6%, p<0.001; Table 3). Both macroscopic and microscopic findings of MVM were more likely to be identified in stillbirths versus livebirths (p<0.001).

Among macroscopic features, placentas associated with stillbirth were more likely to be SGA and have retroplacental hematoma compared to livebirths. Among microscopic features, placentas associated with stillbirth were more likely to have accelerated villous maturity, decidual arteriopathy, and parenchymal infarction. Only diffuse parenchymal infarction (versus focal) was more common in stillbirths versus livebirths. There were no differences in the prevalence of distal villous hypoplasia or increased syncytial knots (Tenney-Parker changes) between stillbirths and livebirths.

Classifying stillbirth based on macroscopic lesions

Logistic regression was able to classify data points as stillbirth versus livebirth based on the presence of macroscopic MVM and FVM features and several maternal factors with an accuracy of 74.4% (95% CI 70.1 – 78.4%), sensitivity of 88.6%, specificity of 42.2%, PPV of 77.7%, and NPV of 62.0%. Unadjusted OR (with 95% CI) for MVM and FVM were 1.48 (1.31 – 1.66) and 1.32 (1.17 – 1.48), respectively (p<0.001); when adjusted for race, ethnicity, maternal age, and history of hypertension or diabetes, these ORs did not significantly change (aOR for MVM = 1.48 [1.30 – 1.69], FVM = 1.34 [1.18 – 1.53], p<0.001).

Discussion

In this study we investigated the association between placental vascular lesions and stillbirth; both MVM and FVM were significantly associated with stillbirth, with a lesion rate of 85.2% for FVM and 81.3% for MVM. This rate is significantly higher than reported in previous literature and emphasizes the role of vascular malperfusion in the etiology of stillbirth. Furthermore, we were able to identify the odds ratios for stillbirth versus livebirth based on the presence of macroscopic MVM and FVM features, which may be useful for pathologists when microscopic examination is not available.

MVM and FVM lesions were both incredibly common in stillbirths, though certain macroscopic features were present more often across the sample. Over half (50.7%) of umbilical cords associated with stillbirth had nuchal entanglement; indeed, umbilical cord accidents account for cause of death in 10% of stillbirths and are thought to be related to fetal hyperactivity and uterine stimulation [19]. However, the presence of nuchal cord entanglement alone is not necessarily associated with increased risk of stillbirth, implying that other factors may be contributing to these antenatal deaths that should be investigated thoroughly when nuchal entanglement is present [20]. A large portion (33.2%) of these stillbirths also were associated with increased cord coiling, which, similarly, does not alone predict stillbirth; rather, umbilical coiling index > 90th percentile for gestational age is associated with a multitude of adverse outcomes in addition to fetal death, including preterm birth, intrapartum fetal distress with need for interventional delivery, meconium-stained amniotic fluid, fetal anomalies, and acidosis [21,22].

Among macroscopic MVM lesions, SGA placenta was found commonly in stillbirths (54.8%); many factors appear to contribute to SGA placentas, including low levels of placental growth factor, epigenetic changes affecting growth, and clinical complications such as hypertension, therefore making it difficult to pinpoint a specific cause of stillbirth in these cases [23-25]. As stillbirths and preterm births due to hypertensive disorders often share placental findings, it is significant that macroscopic MVM findings were more common in stillbirths versus preterm livebirths, though microscopic findings were similar in prevalence. This may point to the high rates of obstetric complications among our preterm livebirth sample. Retroplacental hematoma was less common but still prevalent among stillbirths (22.7%); of note, clinically-identified abruption was not necessarily associated with macroscopic placental hematoma. Failure to promptly diagnose placental abruption is often cited in malpractice cases, making this distinction particularly important in medicolegal settings [26,27]. Macroscopic examination of the placenta at the time of delivery, by midwives or obstetricians, may reveal true attached retroplacental blood clots and suggest chronic MVM, which also has significant legal (and clinical) implications [28,29]. These findings can help adjudicate these cases, as well as provide an explanation for a patient’s or plaintiff’s distress.

There exists overlap between antemortem and postmortem findings of FVM, which may be delineated by clinical findings (e.g., clinical identification of fetal demise), the extent of maceration, and/or histopathological changes (autolysis within the fetus and/or temporal heterogeneity of findings within the placenta) [30]. On a macroscopic level, this overlap is less significant, given that no macroscopic lesions are shared by antepartum and postmortem FVM findings. Indeed, “umbilical cord at risk” findings are more specific for antemortem FVM than postmortem changes [31]. However, it is important to note for microscopic placental examination that uniform avascular villi or stromal-vascular karyorrhexis may be postmortem, requiring pathologists to distinguish these findings accordingly.

There are several strengths to the SCRN study that add to the validity of our findings. Firstly, all placental examinations were standardized according to SCRN protocols, which mitigates variability among different pathologists. Furthermore, the SCRN data contain a diverse group of participants (approximately 36% Hispanic and 36% minority race), which captures a wide breadth of individuals experiencing stillbirth. Our study should also be interpreted in the context of several limitations. We included an additional set of findings not explicitly stated within the Amsterdam criteria but consistent with other sources in the literature, including those lesions that suggest an “umbilical cord at risk.” This may contribute to the increased rate of FVM lesions observed within the sample but did not impact the rate of MVM lesions we reported [17]. Furthermore, the SCRN data does not include findings that, while traditionally identified microscopically, may be observed on careful macroscopic examination, including parenchymal infarcts, chorionic plate or umbilical thromboses, or large areas of avascular villi. Our data were collected from 2006 to 2009, which may underestimate the impact of evolving environmental, medical, and social factors on etiologies of stillbirth. Though we assessed differences between stillbirths and livebirths in this study, we did not control for factors such as neonatal morbidity or mortality; future analyses of this cohort of placentas may seek to determine differences in placental pathologies among all adverse pregnancy outcomes. Finally, though macroscopic lesions of MVM and FVM were associated with higher odds of stillbirth versus livebirth, NPV and specificity were low (62.0% and 42.2%, respectively), likely due to the high prevalence of these lesions within the livebirth sample; the predictive capacity of these lesions therefore needs to be assessed in an external sample.

Maternal vascular malperfusion and fetal vascular malperfusion are common abnormalities that may be identified through macroscopic placental examination. Further studies will continue to elucidate the macroscopic correlates of these findings to further assist general pathologists, obstetricians, and midwives in identifying at-risk placental features such as these that may have implications for further childbearing.

Supplementary Material

1

Highlights.

  • The Stillbirth Collaborative Research Network data contains comprehensive placental examination data for stillbirths.

  • Maternal and fetal vascular malperfusion (MVM, FVM) are associated with stillbirth, with macroscopic lesions more common in stillbirths.

  • These lesions can identify placentas associated with stillbirths versus livebirths.

Funding details

This work was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development: U10-HD045953 Brown University, Rhode Island; U10-HD045925 Emory University, Georgia; U10-HD045952 University of Texas Medical Branch at Galveston, Texas; U10-HDO45955 University of Texas Health Sciences Center at San Antonio, Texas; U10-HD045944 University of Utah Health Sciences Center, Utah; and U01-HD045954 RTI International, RTP. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Abbreviations:

GA

gestational age

MVM

maternal vascular malperfusion

FVM

fetal vascular malperfusion

SCRN

Stillbirth Collaborative Research Network

SGA

small for gestational age

Footnotes

Conflict of interest

The authors have no financial or other conflicts of interest to disclose.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • [1].Kulkarni VG, Sunilkumar KB, Nagaraj TS, Uddin Z, Ahmed I, Hwang K, Goudar SS, Guruprasad G, Saleem S, Tikmani SS, Dhaded SM, Yogeshkumar S, Somannavar MS, McClure EM, Goldenberg RL, Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study, Am J Obstet Gynecol. 225 (2021) 660.e1–660.e12. 10.1016/J.AJOG.2021.06.001. [DOI] [PubMed] [Google Scholar]
  • [2].Wright E, Audette MC, Ye XY, Keating S, Hoffman B, Lye SJ, Shah PS, Kingdom JC, Maternal vascular malperfusion and adverse perinatal outcomes in low-risk nulliparous women, Obstetrics and Gynecology. 130 (2017) 1112–1120. 10.1097/AOG.0000000000002264. [DOI] [PubMed] [Google Scholar]
  • [3].Christians JK, Huicochea Munoz MF, Pregnancy complications recur independently of maternal vascular malperfusion lesions, PLoS One. 15 (2020) e0228664. 10.1371/JOURNAL.PONE.0228664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Gibbins KJ, Silver RM, Pinar H, Reddy UM, Parker CB, Thorsten V, Willinger M, Dudley DJ, Bukowski R, Saade GR, Koch MA, Conway D, Hogue CJ, Stoll BJ, Goldenberg RL, Stillbirth, hypertensive disorders of pregnancy, and placental pathology, Placenta. 43 (2016) 61–68. 10.1016/J.PLACENTA.2016.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Man J, Hutchinson JC, Heazell AE, Ashworth M, Jeffrey I, Sebire NJ, Stillbirth and intrauterine fetal death: role of routine histopathological placental findings to determine cause of death, Ultrasound in Obstetrics & Gynecology. 48 (2016) 579–584. 10.1002/UOG.16019. [DOI] [PubMed] [Google Scholar]
  • [6].Kulkarni AD, Palaniappan N, Evans MJ, Placental Pathology and Stillbirth: A Review of the Literature and Guidelines for the Less Experienced, Journal of Fetal Medicine 2017 4:4. 4 (2017) 177–185. 10.1007/S40556-017-0133-3. [DOI] [Google Scholar]
  • [7].Stanek J, Placental examination in nonmacerated stillbirth versus neonatal mortality, J Perinat Med. 46 (2018) 323–331. 10.1515/JPM-2017-0198/MACHINEREADABLECITATION/RIS. [DOI] [PubMed] [Google Scholar]
  • [8].Redline RW, The clinical implications of placental diagnoses, Semin Perinatol. 39 (2015) 2–8. 10.1053/J.SEMPERI.2014.10.002. [DOI] [PubMed] [Google Scholar]
  • [9].Marchetti D, Belviso M, Fulcheri E, A case of stillbirth: The importance of placental investigation in medico-legal practice, American Journal of Forensic Medicine and Pathology. 30 (2009) 64–68. 10.1097/PAF.0B013E318187387E. [DOI] [PubMed] [Google Scholar]
  • [10].Tou-En Chang K, TE Chang K, TE CK, Pathological examination of the placenta: Raison d’être, clinical relevance and medicolegal utility, Singapore Med J. 50 (2009) 1123–1133. [PubMed] [Google Scholar]
  • [11].Parker CB, Hogue CJR, Koch MA, Willinger M, Reddy UM, Thorsten VR, Dudley DJ, Silver RM, Coustan D, Saade GR, Conway D, Varner MW, Stoll B, Pinar H, Bukowski R, Carpenter M, Goldenberg R, Stillbirth Collaborative Research Network: design, methods and recruitment experience, Paediatr Perinat Epidemiol. 25 (2011) 425–435. 10.1111/J.1365-3016.2011.01218.X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Dudley DJ, Goldenberg R, Conway D, Silver RM, Saade GR, Varner MW, Pinar H, Coustan D, Bukowski R, Stoll B, Koch MA, Parker CB, Reddy UM, A new system for determining the causes of stillbirth, Obstetrics and Gynecology. 116 (2010) 254–260. 10.1097/AOG.0B013E3181E7D975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Pinar H, Koch MA, Hawkins H, Heim-Hall J, Shehata B, Thorsten VR, Carpenter M, Lowichik A, Reddy UM, The Stillbirth Collaborative Research Network (SCRN) Placental and Umbilical Cord Examination Protocol, Am J Perinatol. 28 (2011) 781. 10.1055/S-0031-1281509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Pinar H, Koch M, Hawkins H, Heim-Hall J, Abramowsky C, Thorsten V, Carpenter M, Zhou H, Reddy U, The stillbirth collaborative research network postmortem examination protocol, Am J Perinatol. 29 (2012) 187–202. 10.1055/S-0031-1284228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Pinar H, Sung CJ, Oyer CE, Singer DB, Reference values for singleton and twin placental weights, Pediatr Pathol Lab Med. 16 (1996) 901–907. 10.1080/15513819609168713. [DOI] [PubMed] [Google Scholar]
  • [16].Ernst LM, Maternal vascular malperfusion of the placental bed, APMIS. 126 (2018) 551–560. 10.1111/APM.12833. [DOI] [PubMed] [Google Scholar]
  • [17].Redline RW, Ravishankar S, Fetal vascular malperfusion, an update, APMIS. 126 (2018) 561–569. 10.1111/APM.12849. [DOI] [PubMed] [Google Scholar]
  • [18].Khong TY, Mooney EE, Ariel I, Balmus NCM, Boyd TK, Brundler MA, Derricott H, Evans MJ, Faye-Petersen OM, Gillan JE, Heazell AEP, Heller DS, Jacques SM, Keating S, Kelehan P, Maes A, McKay EM, Morgan TK, Nikkels PGJ, Parks WT, Redline RW, Scheimberg I, Schoots MH, Sebire NJ, Timmer A, Turowski G, Van Der Voorn JP, Van Lijnschoten I, Gordijn SJ, Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement, Arch Pathol Lab Med. 140 (2016) 698–713. 10.5858/ARPA.2015-0225-CC. [DOI] [PubMed] [Google Scholar]
  • [19].Collins JH, Umbilical cord accidents, BMC Pregnancy Childbirth. 12 (2012) 1–2. 10.1186/1471-2393-12-S1-A7/METRICS.22230245 [DOI] [Google Scholar]
  • [20].Larson JD, Rayburn WF, Harlan VL, Nuchal cord entanglements and gestational age, Am J Perinatol. 14 (1997) 555–557. 10.1055/S-2007-994333/BIB. [DOI] [PubMed] [Google Scholar]
  • [21].Pergialiotis V, Kotrogianni P, Koutaki D, Christopoulos-Timogiannakis E, Papantoniou N, Daskalakis G, Umbilical cord coiling index for the prediction of adverse pregnancy outcomes: a meta-analysis and sequential analysis, Journal of Maternal-Fetal and Neonatal Medicine. 33 (2020) 4022–4029. 10.1080/14767058.2019.1594187/SUPPL_FILE/IJMF_A_1594187_SM6954.DOCX. [DOI] [PubMed] [Google Scholar]
  • [22].Ernst LM, Minturn L, Huang MH, Curry E, Su EJ, Gross patterns of umbilical cord coiling: Correlations with placental histology and stillbirth, Placenta. 34 (2013) 583–588. 10.1016/J.PLACENTA.2013.04.002. [DOI] [PubMed] [Google Scholar]
  • [23].Starikov R, Has P, Wu R, Nelson DM, He M, Small-for-gestational age placentas associate with an increased risk of adverse outcomes in pregnancies complicated by either type I or type II pre-gestational diabetes mellitus, 10.1080/14767058.2020.1767572. 35 (2020) 1677–1682. 10.1080/14767058.2020.1767572. [DOI] [PubMed] [Google Scholar]
  • [24].Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Shirasuna K, Matsubara S, Independent risk factors for a small placenta and a small-for-gestational-age infant at 35–41 weeks of gestation: An association with circulating angiogenesis-related factor levels at 19–31 weeks of gestation, Journal of Obstetrics and Gynaecology Research. 43 (2017) 1285–1292. 10.1111/JOG.13360. [DOI] [PubMed] [Google Scholar]
  • [25].Guo L, Choufani S, Ferreira J, Smith A, Chitayat D, Shuman C, Uxa R, Keating S, Kingdom J, Weksberg R, Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae, Dev Biol. 320 (2008) 79–91. 10.1016/J.YDBIO.2008.04.025. [DOI] [PubMed] [Google Scholar]
  • [26].Saccone G, Maruotti GM, Paternoster M, Martinelli P, Diagnosis of placental abruption: a legal issue for physicians, J Matern Fetal Neonatal Med. 29 (2016) 4035–4036. 10.3109/14767058.2016.1153061. [DOI] [PubMed] [Google Scholar]
  • [27].Heller DS, Keane-Tarchichi M, Varshney S, Is pathologic confirmation of placental abruption more reliable in cases due to chronic etiologies compared with acute etiologies?, J Perinat Med. 41 (2013) 701–703. 10.1515/JPM-2013-0064/MACHINEREADABLECITATION/RIS. [DOI] [PubMed] [Google Scholar]
  • [28].Elsasser DA, Ananth CV, Prasad V, Vintzileos AM, Diagnosis of placental abruption: relationship between clinical and histopathological findings, European Journal of Obstetrics & Gynecology and Reproductive Biology. 148 (2010) 125–130. 10.1016/J.EJOGRB.2009.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Ananth CV, Oyelese Y, Prasad V, Getahun D, Smulian JC, Evidence of placental abruption as a chronic process: Associations with vaginal bleeding early in pregnancy and placental lesions, European Journal of Obstetrics & Gynecology and Reproductive Biology. 128 (2006) 15–21. 10.1016/J.EJOGRB.2006.01.016. [DOI] [PubMed] [Google Scholar]
  • [30].Boyd TK, The placenta in intrauterine demise, Journal of Pathology, Microbiology, and Immunology. 126 (2018) 621–625. 10.1111/apm.12832. [DOI] [PubMed] [Google Scholar]
  • [31].Parast MM, Placental findings in cord accidents, BMC Pregnancy Childbirth. 12 (2012) 4437. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES